Transcat, Inc. (NASDAQ:TRNS) Position Raised by Champlain Investment Partners LLC

Champlain Investment Partners LLC increased its position in shares of Transcat, Inc. (NASDAQ:TRNS) by 22.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 409,500 shares of the scientific and technical instruments company’s stock after purchasing an additional 74,169 shares during the period. Champlain Investment Partners LLC owned 4.45% of Transcat worth $49,455,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC raised its holdings in Transcat by 17.9% during the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after purchasing an additional 137,830 shares in the last quarter. Royce & Associates LP increased its holdings in shares of Transcat by 8.2% in the third quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock valued at $61,798,000 after buying an additional 38,774 shares in the last quarter. Hood River Capital Management LLC increased its holdings in shares of Transcat by 21.6% in the second quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock valued at $23,558,000 after buying an additional 34,947 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Transcat by 28.8% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock valued at $9,577,000 after buying an additional 17,743 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Transcat by 2.8% in the third quarter. Charles Schwab Investment Management Inc. now owns 74,832 shares of the scientific and technical instruments company’s stock valued at $9,037,000 after buying an additional 2,008 shares in the last quarter. Institutional investors own 98.34% of the company’s stock.

Transcat Stock Up 2.1 %

NASDAQ:TRNS opened at $109.02 on Friday. Transcat, Inc. has a 12-month low of $94.29 and a 12-month high of $147.12. The firm has a market capitalization of $1.00 billion, a PE ratio of 55.06 and a beta of 0.69. The firm has a 50-day moving average price of $116.61 and a 200 day moving average price of $121.50.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The company had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. During the same period last year, the company earned $0.41 earnings per share. Transcat’s revenue for the quarter was up 8.0% compared to the same quarter last year. On average, research analysts expect that Transcat, Inc. will post 1.76 EPS for the current year.

Analyst Ratings Changes

TRNS has been the topic of several research reports. HC Wainwright reaffirmed a “buy” rating and issued a $156.00 price target on shares of Transcat in a report on Tuesday, October 29th. Northland Securities dropped their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating on the stock in a report on Wednesday, October 30th. Oppenheimer reissued an “outperform” rating and set a $130.00 target price (down from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th. Finally, Craig Hallum cut their target price on shares of Transcat from $138.00 to $113.00 and set a “buy” rating on the stock in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $127.25.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.